Nucleosides

5-(1-Propynyl)-2'-O-methylcytidine

Description: 5-(1-Propynyl)-2'-O-methylcytidine is a robust and efficacious antiviral compound, finding profound utility in the research of various virological malaises such as respiratory syncytial virus (RSV), influenza and hemorrhagic fever viruses. Its mechanism of action lies in thwarting viral replication and averting viral dissemination within the host organism.

CAT: BRP-01700

CAS: 179817-96-0

Molecular Formula: C13H17N3O5

Molecular Weight: 295.29

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.47±0.1 g/cm3

Boiling Point: 522.4±60.0 °C at 760 mmHg

InChIKey: RDNYOZGTGXUIIY-DNRKLUKYSA-N

CanonicalSMILES: CC#CC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)OC

IUPAC Name: 4-amino-1-[(2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxyoxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one

InChI: InChI=1S/C13H17N3O5/c1-3-4-7-5-16(13(19)15-11(7)14)12-10(20-2)9(18)8(6-17)21-12/h5,8-10,12,17-18H,6H2,1-2H3,(H2,14,15,19)/t8-,9-,10-,12-/m1/s1

Synonyms: 5-Propynyl-2'-(O-Methyl) Cytidine; Cytidine, 2'-O-methyl-5-(1-propynyl)-; 4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-methoxytetrahydrofuran-2-yl)-5-(prop-1-yn-1-yl)pyrimidin-2(1H)-one; 2'-O-Methyl-5-prop-1-yn-1-ylcytidine

3'-O-Allyladenosine

Description: 3'-O-Allyladenosine, a vital compound in the field of biomedicine, serves as a fundamental element for investigating adenosine receptors. These receptors, implicated in a multitude of ailments encompassing cardiovascular disorders, immunological responses, and neurodegenerative afflictions, hold great importance. This particular product is frequently employed to delve into the potential therapeutic applications of adenosine receptor modulation, specifically targeting conditions like ischemic heart disease, asthma, and malignancies.

CAT: BRP-01701

CAS: 400820-99-7

Molecular Formula: C13H17N5O4

Molecular Weight: 307.31

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.66±0.1 g/cm3

Boiling Point: 632.8±65.0 °C at 760 mmHg

InChIKey: KURUYHOEDIRMCE-QYVSTXNMSA-N

CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=NC3=C(N=CN=C32)N)CO

IUPAC Name: (2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-3-ol

InChI: InChI=1S/C13H17N5O4/c1-2-3-21-10-7(4-19)22-13(9(10)20)18-6-17-8-11(14)15-5-16-12(8)18/h2,5-7,9-10,13,19-20H,1,3-4H2,(H2,14,15,16)/t7-,9-,10-,13-/m1/s1

Synonyms: 3'-O-Allyl-D-adenosine; 3'-(O-allyl) Adenosine; 3'-O-allyl Adenosine; (2R,3R,4S,5R)-4-(allyloxy)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3-ol; 3'-O-2-Propen-1-yladenosine

3'-O-Allylguanosine

Description: 3'-O-Allylguanosine, a widely used biomedicine product in research, presents itself as a paramount avenue to explore the antiviral properties exhibited by guanosine derivatives. Its prominent role extends to serving as a pivotal reference compound, wherein its efficacy in combating viral infections, namely HIV, hepatitis, and respiratory viruses, can be meticulously evaluated.

CAT: BRP-01702

Molecular Formula: C13H17N5O5

Molecular Weight: 323.30

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: XCRVSUORBIBONA-WOUKDFQISA-N

CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=NC3=C2N=C(NC3=O)N)CO

IUPAC Name: 2-amino-9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]-1H-purin-6-one

InChI: InChI=1S/C13H17N5O5/c1-2-3-22-9-6(4-19)23-12(8(9)20)18-5-15-7-10(18)16-13(14)17-11(7)21/h2,5-6,8-9,12,19-20H,1,3-4H2,(H3,14,16,17,21)/t6-,8-,9-,12-/m1/s1

Synonyms: 3'-(O-allyl) Guanosine; 3'-O-Allyl-D-guanosine; 9-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-amino-1,9-dihydro-6H-purin-6-one

3'-O-Allyluridine

Description: 3'-O-Allyluridine, a vital compound extensively employed in the biomedical sector, plays a pivotal role in combating diverse ailments. Brimming with extraordinary antiviral and anticancer attributes, this remarkable entity boasts immense worth in the realm of antiviral medications and chemotherapeutic agents. With its profound ability to specifically target and impede the replication of both viruses and malignant cells, this compound unfurls a vast array of prospects for potential therapeutic interventions against viral infections and neoplastic disorders.

CAT: BRP-01703

Molecular Formula: C12H16N2O6

Molecular Weight: 284.27

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: PVPSBJHKGXULPJ-QCNRFFRDSA-N

CanonicalSMILES: C=CCOC1C(OC(C1O)N2CCC(=O)NC2=O)CO

IUPAC Name: 1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]-1,3-diazinane-2,4-dione

InChI: InChI=1S/C12H18N2O6/c1-2-5-19-10-7(6-15)20-11(9(10)17)14-4-3-8(16)13-12(14)18/h2,7,9-11,15,17H,1,3-6H2,(H,13,16,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 3'-(O-allyl) Uridine; 3'-O-Allyl-D-uridine; 1-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione

3'-O-Allylcytidine

Description: 3'-O-Allylcytidine, a cutting-edge biomedical innovation, stands as a pivotal resource in combating a wide range of diseases. It showcases an exquisite modification of cytidine, unveiling extraordinary potential in the selective eradication of cancerous cells and hindering their malignant proliferation. Furthermore, this compound's remarkable antiviral attributes have garnered significant attention, empowering its utilization against specific strains of viral infections.

CAT: BRP-01704

Molecular Formula: C12H17N3O5

Molecular Weight: 283.28

Purity: 98%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: SUDPDZLUFKFRMW-QCNRFFRDSA-N

CanonicalSMILES: C=CCOC1C(OC(C1O)N2C=CC(=NC2=O)N)CO

IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-enoxyoxolan-2-yl]pyrimidin-2-one

InChI: InChI=1S/C12H17N3O5/c1-2-5-19-10-7(6-16)20-11(9(10)17)15-4-3-8(13)14-12(15)18/h2-4,7,9-11,16-17H,1,5-6H2,(H2,13,14,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 3'-O-Allyl-D-cytidine; 3'-(O-allyl) Cytidine; 1-((2R,3R,4S,5R)-4-(allyloxy)-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-4-aminopyrimidin-2(1H)-one

3'-O-Methylinosine

Description: 3'-O-Methylinosine is a cutting-edge compound, exhibiting tremendous promise in the research of various diseases. Its therapeutic efficacy stems from its exquisite chemical composition, meticulously designed to selectively target and combat specific drugs or diseases.

CAT: BRP-01705

CAS: 75479-64-0

Molecular Formula: C11H14N4O5

Molecular Weight: 282.25

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.84±0.1 g/cm3

Boiling Point: 724.3±60.0 °C at 760 mmHg

InChIKey: ABXDBVMGRKZFRC-IOSLPCCCSA-N

CanonicalSMILES: COC1C(OC(C1O)N2C=NC3=C2N=CNC3=O)CO

IUPAC Name: 9-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-1H-purin-6-one

InChI: InChI=1S/C11H14N4O5/c1-19-8-5(2-16)20-11(7(8)17)15-4-14-6-9(15)12-3-13-10(6)18/h3-5,7-8,11,16-17H,2H2,1H3,(H,12,13,18)/t5-,7-,8-,11-/m1/s1

Synonyms: 3'-(O-Methyl) Inosine; 3'-O-Methyl-D-inosine; 9-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one; 3'-OMe-I

3'-O-Methyl-5-methylcytidine

Description: 3'-O-Methyl-5-methylcytidine, a remarkable and powerful biomedicine, emerges as an indispensable weapon combating a wide spectrum of afflictions. Its paramount significance permeates the intricate orchestration of cellular dynamics and genetic predisposition. Fashioned with an unparalleled molecular framework, this extraordinary compound unveils a shimmering horizon for revolutionizing cancer therapy, battling relentless viral invasions, and addressing enigmatic autoimmune maladies.

CAT: BRP-01706

CAS: 2086327-74-2

Molecular Formula: C11H17N3O5

Molecular Weight: 271.27

Purity: ≥98%

Appearance: White to off-white powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.61±0.1 g/cm3

Boiling Point: 504.6±60.0 °C at 760 mmHg

InChIKey: NQWWPNJIDJMFGO-FDDDBJFASA-N

CanonicalSMILES: CC1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)OC)O

IUPAC Name: 4-amino-1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxyoxolan-2-yl]-5-methylpyrimidin-2-one

InChI: InChI=1S/C11H17N3O5/c1-5-3-14(11(17)13-9(5)12)10-7(16)8(18-2)6(4-15)19-10/h3,6-8,10,15-16H,4H2,1-2H3,(H2,12,13,17)/t6-,7-,8-,10-/m1/s1

Synonyms: 3'-O-Methyl-5-methyl-D-cytidine; 3'-(O-Methyl)-5-Methyl Cytidine; 4-Amino-5-methyl-1-(3-O-methyl-β-D-xylofuranosyl)-2(1H)-pyrimidinone; 4-amino-1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-methoxytetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one

3'-O-Propargyluridine

Description: 3'-O-Propargyluridine, an exceptional biomedical advancement, emerges as a prominent combatant against formidable viral afflictions like COVID-19. Its unparalleled antiviral capabilities lie in its profound ability to impede the replication of viral RNA. Additionally, this extraordinary compound serves as an invaluable tool for delving into the intricate realm of RNA modifications, RNA labeling, and nucleic acid-based therapeutic methodologies.

CAT: BRP-01707

CAS: 129778-59-2

Molecular Formula: C12H14N2O6

Molecular Weight: 282.25

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.52±0.1 g/cm3

InChIKey: LYDAINNGFSGRDR-QCNRFFRDSA-N

CanonicalSMILES: C#CCOC1C(OC(C1O)N2C=CC(=O)NC2=O)CO

IUPAC Name: 1-[(2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-prop-2-ynoxyoxolan-2-yl]pyrimidine-2,4-dione

InChI: InChI=1S/C12H14N2O6/c1-2-5-19-10-7(6-15)20-11(9(10)17)14-4-3-8(16)13-12(14)18/h1,3-4,7,9-11,15,17H,5-6H2,(H,13,16,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 3'-O-Propargyl-D-uridine; 3'-(O-propargyl) Uridine; 3'-(O-Propargyl)uridine; 1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 3'-O-2-propynyluridine

3'-O-Propargylcytidine

Description: 3'-O-Propargylcytidine, a powerful antiviral agent, is extensively employed to combat various viral infections induced by RNA viruses. By inhibiting viral replication and suppressing viral protein synthesis, this exceptional compound manifests remarkable efficacy against diverse viral strains. Its therapeutic potential has been demonstrated in managing RNA virus-associated disorders, encompassing respiratory tract infections, hepatitis, and influenza.

CAT: BRP-01708

CAS: 1451256-00-0

Molecular Formula: C12H15N3O5

Molecular Weight: 281.26

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.51±0.1 g/cm3

Boiling Point: 544.7±60.0 °C at 760 mmHg

InChIKey: QCHWARZEPUERNY-QCNRFFRDSA-N

CanonicalSMILES: O=C1N=C(N)C=CN1C2OC(CO)C(OCC#C)C2O

IUPAC Name: 4-amino-1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

InChI: InChI=1S/C12H15N3O5/c1-2-5-19-10-7(6-16)20-11(9(10)17)15-4-3-8(13)14-12(15)18/h1,3-4,7,9-11,16-17H,5-6H2,(H2,13,14,18)/t7-,9-,10-,11-/m1/s1

Synonyms: 3'-(O-propargyl) Cytidine; 3'-O-Propargyl-D-cytidine; 3'-O-2-Propyn-1-ylcytidine; 3'-(O-Propargyl)cytidine; 4-amino-1-((2R,3R,4S,5R)-3-hydroxy-5-(hydroxymethyl)-4-(prop-2-yn-1-yloxy)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

5'-DMT-2'-(O-methyl)-guanosine (N-PAC)

Description: 5'-DMT-2'-(O-methyl)-guanosine (N-PAC) is a remarkable pharmacological compound, extensively employed in the research of select malignant neoplasms and viral afflictions. Its formidable inhibitory potential derives from its adeptness at thwarting viral RNA and DNA duplication, effectively thwarting the advance of afflictions birthed by these pathogens.

CAT: BRP-01709

CAS: 138906-94-2

Molecular Formula: C40H39N5O9

Molecular Weight: 733.77

Purity: ≥98% by HPLC

Appearance: white crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.36±0.1 g/cm3

InChIKey: HVGFIPCWVIUNMP-BBKOCAQVSA-N

Solubility: Soluble in acetonitrile

CanonicalSMILES: COC1C(C(OC1N2C=NC3=C2N=C(NC3=O)NC(=O)COC4=CC=CC=C4)COC(C5=CC=CC=C5)(C6=CC=C(C=C6)OC)C7=CC=C(C=C7)OC)O

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-phenoxyacetamide

InChI: InChI=1S/C40H39N5O9/c1-49-28-18-14-26(15-19-28)40(25-10-6-4-7-11-25,27-16-20-29(50-2)21-17-27)53-22-31-34(47)35(51-3)38(54-31)45-24-41-33-36(45)43-39(44-37(33)48)42-32(46)23-52-30-12-8-5-9-13-30/h4-21,24,31,34-35,38,47H,22-23H2,1-3H3,(H2,42,43,44,46,48)/t31-,34-,35-,38-/m1/s1

Synonyms: 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-phenoxyacetyl)guanosine; 5'-DMT-2'-O-Me G(PAC); 5'-DMT-2'-(O-Methyl) Guanosine (n-PAC)

5'-DMT-2'-(O-methyl)-cytidine (N-PAC)

Description: 5'-DMT-2'-(O-methyl)-cytidine (N-PAC) is a formidable antiviral compound deployed in the research of viral afflictions, with an emphasized efficacy against RNA viruses. Its research of antiviral range expands fervently, encompassing the likes of influenza and hepatitis C.

CAT: BRP-01710

Molecular Formula: C39H39N3O9

Molecular Weight: 693.74

Purity: ≥98% by HPLC

Appearance: white crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: PHESFPHFNNTKHW-QPCXHTPLSA-N

Solubility: Soluble in acetonitrile

IUPAC Name: N-(1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)-2-phenoxyacetamide

InChI: InChI=1S/C39H39N3O9/c1-46-29-18-14-27(15-19-29)39(26-10-6-4-7-11-26,28-16-20-30(47-2)21-17-28)50-24-32-35(44)36(48-3)37(51-32)42-23-22-33(41-38(42)45)40-34(43)25-49-31-12-8-5-9-13-31/h4-23,32,35-37,44H,24-25H2,1-3H3,(H,40,41,43,45)/t32-,35-,36-,37-/m1/s1

Synonyms: 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-N-(2-phenoxyacetyl)cytidine; 5'-DMT-2'-O-Me C(PAC)

5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine

Description: 5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine is a crucial compound used for the research and development of nucleic acid analogs. With its unique chemical structure, it finds application as a building block for modified oligonucleotides. This compound has various potential uses, including the research of viral diseases, cancer and genetic disorders. Its versatile nature makes it an essential tool in drug discovery and the development of targeted therapies.

CAT: BRP-01711

CAS: 644962-77-6

Molecular Formula: C34H34N2O8

Molecular Weight: 598.65

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: LVHXICIDKOYPHH-PBAMLIMUSA-N

CanonicalSMILES: CC#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)OC

IUPAC Name: 1-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione

InChI: InChI=1S/C34H34N2O8/c1-5-9-22-20-36(33(39)35-31(22)38)32-30(42-4)29(37)28(44-32)21-43-34(23-10-7-6-8-11-23,24-12-16-26(40-2)17-13-24)25-14-18-27(41-3)19-15-25/h6-8,10-20,28-30,32,37H,21H2,1-4H3,(H,35,38,39)/t28-,29-,30-,32-/m1/s1

Synonyms: 5'-DMT-5-Propynyl-2'-(O-Methyl) Uridine; 1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-5-(prop-1-yn-1-yl)pyrimidine-2,4(1H,3H)-dione; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-O-methyl-5-(1-propynyl)-

N4-Benzoyl-5'-O-DMT-5-methylcytidine

Description: N4-Benzoyl-5'-O-DMT-5-methylcytidine is an extensively researched biomedical compound, aiding in studying diverse ailments. Its efficacy lies in its capacity to precisely target and modulate RNA and DNA alterations, thereby impeding the growth and propagation of malignant cells.

CAT: BRP-01712

CAS: 160107-17-5

Molecular Formula: C38H37N3O8

Molecular Weight: 663.72

Purity: ≥95%

Appearance: White Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at RT

Density: 1.3±0.1 g/cm3

InChIKey: QCKRNDPKDFQXCO-DHKUXYTCSA-N

CanonicalSMILES: CC1=CN(C(=O)N=C1NC(=O)C2=CC=CC=C2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)O

IUPAC Name: N-(1-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide

InChI: InChI=1S/C38H37N3O8/c1-24-22-41(37(45)40-34(24)39-35(44)25-10-6-4-7-11-25)36-33(43)32(42)31(49-36)23-48-38(26-12-8-5-9-13-26,27-14-18-29(46-2)19-15-27)28-16-20-30(47-3)21-17-28/h4-22,31-33,36,42-43H,23H2,1-3H3,(H,39,40,44,45)/t31-,32-,33-,36-/m1/s1

Synonyms: 5'-DMT-5-Methyl Cytidine (n-bz); N4-Benzoyl-5'-O-(4,4'-dimethoxytrityl)-5-methylcytidine; N4-Benzoyl-5'-O-dimethoxytrityl-5-methylcytidine; N-(1-((2R,3R,4S,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-5-methyl-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide; 5'-O-(4,4'-dimethoxitrityl)-N-benzoyl-5-methylcytidine; N-Benzoyl-5'-O-[bis(4-methoxyphenyl)(phenyl)methyl]-5-methylcytidine

5'-DMT-5-propynyl-uridine

Description: 5'-DMT-5-propynyl-uridine, a modified version of uridine, is a potential therapeutic agent for fighting against neurological diseases including Alzheimer's and Parkinson's. Scientific studies have revealed that it could enhance cognitive function whilst also exhibiting excellent anti-inflammatory properties. With high demand in the biomedical industry, this product holds great promise for those looking to alleviate the negative effects of these devastating diseases.

CAT: BRP-01713

CAS: 644962-76-5

Molecular Formula: C33H32N2O8

Molecular Weight: 584.62

Purity: ≥98% by HPLC

Appearance: white crystalline powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

InChIKey: VFKJTINFVHDNPY-BUVRPPHQSA-N

Solubility: Soluble in acetonitrile

CanonicalSMILES: CC#CC1=CN(C(=O)NC1=O)C2C(C(C(O2)COC(C3=CC=CC=C3)(C4=CC=C(C=C4)OC)C5=CC=C(C=C5)OC)O)O

IUPAC Name: 1-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione

InChI: InChI=1S/C33H32N2O8/c1-4-8-21-19-35(32(39)34-30(21)38)31-29(37)28(36)27(43-31)20-42-33(22-9-6-5-7-10-22,23-11-15-25(40-2)16-12-23)24-13-17-26(41-3)18-14-24/h5-7,9-19,27-29,31,36-37H,20H2,1-3H3,(H,34,38,39)/t27-,28-,29-,31-/m1/s1

Synonyms: 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-5-prop-1-yn-1-yluridine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-5-(1-propyn-1-yl)uridine; Uridine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-5-(1-propynyl)-; 5'-DMT-5-Propynyl Uridine

2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine

Description: 2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine, a compound hailed within the biomedical industry, exhibiting intriguing medicinal potential. It serves as a catalyst in the creation of tailored therapeutics, meticulously designed to thwart precise pathways by selectively maneuvering functions.

CAT: BRP-01714

CAS: 869354-79-0

Molecular Formula: C39H45N7O7

Molecular Weight: 723.84

Purity: ≥97%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.29±0.1 g/cm3

InChIKey: HUYROJQAEKXGHQ-GONXPTGJSA-N

CanonicalSMILES: CC(C)C(=O)NC1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC)N=CN(C)C

IUPAC Name: N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-(dimethylaminomethylideneamino)purin-2-yl]-2-methylpropanamide

InChI: InChI=1S/C39H45N7O7/c1-24(2)36(48)44-38-42-34(41-22-45(3)4)31-35(43-38)46(23-40-31)37-33(51-7)32(47)30(53-37)21-52-39(25-11-9-8-10-12-25,26-13-17-28(49-5)18-14-26)27-15-19-29(50-6)20-16-27/h8-20,22-24,30,32-33,37,47H,21H2,1-7H3,(H,42,43,44,48)/t30-,32-,33-,37-/m1/s1

Synonyms: Adenosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-N-[(dimethylamino)methylene]-2'-O-methyl-2-[(2-methyl-1-oxopropyl)amino]-; N-(9-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-6-(((dimethylamino)methylene)amino)-9H-purin-2-yl)isobutyramide; 2'-OMe-5'-DMT-2,6-diamino purine riboside (n6,n6-dmf) (n2-ibu); 2'-OMe-5'-DMT-N2-amino-ibu rA(N6-DMF)

5'-O-DMT-N6-(2-phenoxyacetyl)-adenosine

Description: 5'-O-DMT-N6-(2-phenoxyacetyl)-adenosine, a biomedical marvel, takes the forefront in combating a myriad of ailments. Amplifying its potential as an adenosine receptor modulator, it possesses the prowess to intricately manage neurological disorders, cardiac conditions, and inflammatory diseases. Its distinctive chemical structure intertwines with its pharmacological properties, propelling it to the forefront of future biomedical investigations.

CAT: BRP-01715

CAS: 121076-16-2

Molecular Formula: C39H37N5O8

Molecular Weight: 703.74

Purity: ≥95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.36±0.1 g/cm3 (Predicted)

InChIKey: GWFRSQBGIGLMFD-BBKOCAQVSA-N

CanonicalSMILES: COC1=CC=C(C=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OC)OCC4C(C(C(O4)N5C=NC6=C(N=CN=C65)NC(=O)COC7=CC=CC=C7)O)O

IUPAC Name: N-[9-[(2R,3R,4S,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-3,4-dihydroxyoxolan-2-yl]purin-6-yl]-2-phenoxyacetamide

InChI: InChI=1S/C39H37N5O8/c1-48-28-17-13-26(14-18-28)39(25-9-5-3-6-10-25,27-15-19-29(49-2)20-16-27)51-21-31-34(46)35(47)38(52-31)44-24-42-33-36(40-23-41-37(33)44)43-32(45)22-50-30-11-7-4-8-12-30/h3-20,23-24,31,34-35,38,46-47H,21-22H2,1-2H3,(H,40,41,43,45)/t31-,34-,35-,38-/m1/s1

Synonyms: 5'-DMT Adenosine (n-PAC); 5'-O-(4,4'-Dimethoxytrityl)-N6-phenoxyacetyl adenosine; 5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-N6-(2-phenoxyacetyl)adenosine; N-(Phenoxyacetyl)-5'-O-(4,4'-dimethoxytrityl)adenosine; N-(9-((2R,3R,4S,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-6-yl)-2-phenoxyacetamide; 5'-O-[Bis(4-methoxyphenyl)(phenyl)methyl]-N-(phenoxyacetyl)adenosine

7-Deazainosine

Description: 7-Deazainosine is a modified nucleoside derivative that is used in RNA and DNA research. It is a modified form of adenosine where the nitrogen at the 7-position of the purine ring is replaced by a carbon atom. This modification alters the base-pairing properties of the nucleoside, making it useful for studying RNA folding and interactions. Additionally, 7-Deazainosine can also be incorporated into synthetic oligonucleotides for various applications in molecular biology and biotechnology.

CAT: BRP-01717

CAS: 2862-16-0

Molecular Formula: C11H13N3O5

Molecular Weight: 267.24

Purity: 95%

Size	Price	Stock	Quantity
--	--	--

Inquiry

Density: 1.90±0.1 g/cm3

Melting Point: 240 °C

Boiling Point: 679.7±55.0 °C at 760 mmHg

InChIKey: DPRSKJHWKNHBOW-KCGFPETGSA-N

CanonicalSMILES: C1=CN(C2=C1C(=O)NC=N2)C3C(C(C(O3)CO)O)O

IUPAC Name: 7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

InChI: InChI=1S/C11H13N3O5/c15-3-6-7(16)8(17)11(19-6)14-2-1-5-9(14)12-4-13-10(5)18/h1-2,4,6-8,11,15-17H,3H2,(H,12,13,18)/t6-,7-,8-,11-/m1/s1

Synonyms: 7-Deaza ribo Inosine; 3,7-Dihydro-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one; 4H-Pyrrolo[2,3-d]pyrimidin-4-one, 1,7-dihydro-7-β-D-ribofuranosyl-; 7-(β-D-Ribofuranosyl)pyrrolo[2,3-d]pyrimidin-4-one; 7-β-D-Ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-ol; Antibiotic XK 101-2; NSC 99439

7-Deazaguanosine

Description: It is a guanosine analogue with antiviral and anti-HCV activity.

CAT: BRP-01718

CAS: 62160-23-0

Molecular Formula: C11H14N4O5

Molecular Weight: 282.25

Purity: ≥95%

Appearance: Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C under inert atmosphere

Density: 2.06±0.1 g/cm3 (Predicted)

Melting Point: >250°C (dec.)

Boiling Point: 668.3±65.0°C at 760 mmHg

InChIKey: JRYMOPZHXMVHTA-DAGMQNCNSA-N

Solubility: Soluble in Methanol

CanonicalSMILES: C1=CN(C2=C1C(=O)NC(=N2)N)C3C(C(C(O3)CO)O)O

IUPAC Name: 2-amino-7-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one

InChI: InChI=1S/C11H14N4O5/c12-11-13-8-4(9(19)14-11)1-2-15(8)10-7(18)6(17)5(3-16)20-10/h1-2,5-7,10,16-18H,3H2,(H3,12,13,14,19)/t5-,6-,7-,10-/m1/s1

Synonyms: 7-Deaza ribo Guanosine; 2-Amino-7-(β-D-ribofuranosyl)-1,7-dihydro-4H-pyrrolo[2,3-d]pyrimidin-4-one; 2-Amino-1,7-dihydro-7-β-D-ribofuranosyl-4H-pyrrolo[2,3-d]pyrimidin-4-one; 2-Amino-7-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-pyrrolo[2,3-d]pyrimidin-4(7H)-one; N7-Deazaguanosine

β-L-Adenosine

Description: β-L-Adenosine is a versatile biochemical compound extensively employed in the biomedical sector for advanced research studies, showcasing a profound significance in probing its exceptional efficacy against a gamut of ailments, including cancer, viral infections, as well as autoimmune disorders.

CAT: BRP-01727

CAS: 3080-29-3

Molecular Formula: C10H13N5O4

Molecular Weight: 267.24

Purity: ≥97% by HPLC

Appearance: White Crystalline Powder

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at -20°C

Density: 2.08±0.1 g/cm3 (Predicted)

Melting Point: 219-224°C

Boiling Point: 676.3±65.0°C (Predicted)

InChIKey: OIRDTQYFTABQOQ-DEGSGYPDSA-N

Solubility: Soluble in DMSO (Slightly), Methanol (Slightly, Heated)

CanonicalSMILES: C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)O)N

IUPAC Name: (2S,3S,4R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol

InChI: InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m0/s1

Synonyms: Beta-L-ribo Adenosine; L-Adenosine; L-rA; Beta-L-adenosine; (2S,3S,4R,5S)-2-(6-Amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; 9-beta-L-Ribofuranosyladenine; 9-(b-L-Ribofuranosyl)adenine; 9-beta-L-Ribofuranosyl-9H-purine-6-amine

L-Cytidine

Description: L-Cytidine is a prominent bioactive compound employed extensively, emerging as a pivotal compound for the genesis of nucleic acids. Exerting a profound influence on cellular metabolism, it assumes a crucial mantle in studying diverse ailments encompassing viral afflictions, malignant neoplasms and conditions affecting the neurologic milieu.

CAT: BRP-01728

CAS: 26524-60-7

Molecular Formula: C9H13N3O5

Molecular Weight: 243.22

Purity: ≥97% by HPLC

Appearance: White to Off-white Solid

Size	Price	Stock	Quantity
--	--	--

Inquiry

Storage: Store at 2-8°C

Density: 1.89±0.1 g/cm3

Boiling Point: 545.7±60.0 °C at 760 mmHg

InChIKey: UHDGCWIWMRVCDJ-PSQAKQOGSA-N

CanonicalSMILES: C1=CN(C(=O)N=C1N)C2C(C(C(O2)CO)O)O

IUPAC Name: 4-amino-1-[(2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

InChI: InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7-,8-/m0/s1

Synonyms: Beta-L-ribo Cytidine; beta-L-Cytidine; 4-Amino-1-((2S,3S,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one; 1-beta-L-Ribofuranosylcytosine; L-rC; 2(1H)-Pyrimidinone, 4-amino-1-beta-L-ribofuranosyl-; 4-Amino-1-(β-L-ribofuranosyl)-2(1H)-pyrimidinone; β-L-Cytidine

5-(1-Propynyl)-2'-O-methylcytidine

3'-O-Allyladenosine

3'-O-Allylguanosine

3'-O-Allyluridine

3'-O-Allylcytidine

3'-O-Methylinosine

3'-O-Methyl-5-methylcytidine

3'-O-Propargyluridine

3'-O-Propargylcytidine

5'-DMT-2'-(O-methyl)-guanosine (N-PAC)

5'-DMT-2'-(O-methyl)-cytidine (N-PAC)

5'-O-(Dimethoxytrityl)-5-(1-propynyl)-2'-O-methyluridine

N4-Benzoyl-5'-O-DMT-5-methylcytidine

5'-DMT-5-propynyl-uridine

2-Amino-5'-O-(dimethoxytrityl)-N6-(dimethylaminomethylidene)-N2-isobutyryl-2'-O-methyladenosine

5'-O-DMT-N6-(2-phenoxyacetyl)-adenosine

7-Deazainosine

7-Deazaguanosine

β-L-Adenosine

L-Cytidine

Our Products

Liposome Products

MicroRNA Products

mRNA Products

siRNA Products

RNA Synthesis Reagents

Cap Analogs

CPGs for Oligo Synthesis

Nucleosides

Nucleotides

Phosphoramidites